AMERICA'S CORD BLOOD BANK Trademark

Trademark Overview


On Tuesday, August 26, 2003, a trademark application was filed for AMERICA'S CORD BLOOD BANK with the United States Patent and Trademark Office. The USPTO has given the AMERICA'S CORD BLOOD BANK trademark a serial number of 78292087. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 27, 2005. This trademark is owned by Celgene Corporation. The AMERICA'S CORD BLOOD BANK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for use with biological tissue intended for subsequent implantation, namely, blood, stem cells, umbilical cords and placentas for medical and clinical use; pharmaceutical preparations for use in the collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases

research, development and testing services for others in the fields of biotechnology, chemistry and pharmaceuticals

General Information


Serial Number78292087
Word MarkAMERICA'S CORD BLOOD BANK
Filing DateTuesday, August 26, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 27, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for use with biological tissue intended for subsequent implantation, namely, blood, stem cells, umbilical cords and placentas for medical and clinical use; pharmaceutical preparations for use in the collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases
Goods and Servicesresearch, development and testing services for others in the fields of biotechnology, chemistry and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2003
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Friday, May 27, 2005ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 27, 2005ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, October 22, 2004NON-FINAL ACTION E-MAILED
Friday, October 22, 2004NON-FINAL ACTION WRITTEN
Thursday, October 7, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, September 20, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 20, 2004PAPER RECEIVED
Monday, March 22, 2004NON-FINAL ACTION E-MAILED
Sunday, March 14, 2004ASSIGNED TO EXAMINER